The global Stem Cell Bankingmarket was valued at USD 1.52 billion in 2016 and is projected to reach USD 7.94billionby 2025, growing at a CAGR of 20.17% from 2017 to 2025.
Stem Cell banking involves preservation of new born placental stem cells or amniotic stem cells as well as adult bone marrow stem cells. The concept ensures health safety in case of a major surgery or organ regeneration needs for the patient. With increasing awareness regarding the practice, the market is expected to boost in near future.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Easy Extraction Methods
1.2 High birth ratio
1.3 Increase in GDP and Disposable income in developing nations
1.4 Increasing support from public and private sector
1.5 Scope of stem cell usage in therapeutics and treatment
2. Market Restraints
2.1 Large number of players in the market
2.2 High Cost of technology
2.3 Lack of awareness
2.4 Regulatory restrains
Market Segmentation:
1. By Application:
1.1 Cerebral Palsy
1.2 Thalassemia
1.3 Leukemia
1.4 Diabetes
1.5 Autism
1.6 Others
2. By Services:
2.1 Collection & Transportation
2.2 Processing
2.3 Analysis
2.4 Storage
3. By Bank Type:
3.1 Cord Blood
3.2 Cord Tissue
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. CBR Systems, Inc.
2. Cordlife
3. Cryo-Cell
4. Cryo-Save AG (A Group of Esperite)
5. Lifecell
6. Stemcyte
7. Viacord
8. Smart Cells International Ltd.
9. Cryoviva India
10. Cordvida
11. China Cord Blood Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Stem Cell Bankingmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL STEM CELL BANKINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL STEM CELL BANKINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL STEM CELL BANKING MARKET, BY APPLICATION
5.1 Cerebral Palsy
5.2 Thalassemia
5.3 Leukemia
5.4 Diabetes
5.5 Autism
5.6 Others
6 GLOBAL STEM CELL BANKING MARKET, BY SERVICES
6.1 Collection & Transportation
6.2 Processing
6.3 Analysis
6.4 Storage
7 GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE
7.1 Cord Blood
7.2 Cord Tissue
8 GLOBAL STEM CELL BANKINGMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL STEM CELL BANKINGMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 CBR Systems, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Cordlife
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Cryo-Cell
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Cryo-Save AG (A Group of Esperite)
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Lifecell
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Stemcyte
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Viacord
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Smart Cells International Ltd.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Cryoviva India
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development
10.10 Cordvida
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development
10.11 China Cord Blood Corporation
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development
11 Appendix
11.1 Related Reports